Latest Pharma News update... Sep 03
BYVASDA is an anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody and a bevacizumab biosimilar independently developed by Innovent Biologics... Dec 28
Innovent announces NMPA granted new indication approvals for SULINNO (Adalimumab Injection) for the treatment of pediatric plaque psoriasis and non-infectious uveitis ... Dec 24
The survival rate is also relatively higher than other tumour types when having appropriate treatment... Oct 09
-Advertisements-